Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Cerebral Dopamine Neurotrophic Factor Diffuses Around the Brainstem and Does Not Undergo Anterograde Transport After Injection to the Substantia Nigra.

Albert K, Renko JM, Mätlik K, Airavaara M, Voutilainen MH.

Front Neurosci. 2019 Jun 11;13:590. doi: 10.3389/fnins.2019.00590. eCollection 2019.

2.

Two-fold elevation of endogenous GDNF levels in mice improves motor coordination without causing side-effects.

Mätlik K, Võikar V, Vilenius C, Kulesskaya N, Andressoo JO.

Sci Rep. 2018 Aug 8;8(1):11861. doi: 10.1038/s41598-018-29988-1.

3.

Poststroke delivery of MANF promotes functional recovery in rats.

Mätlik K, Anttila JE, Kuan-Yin T, Smolander OP, Pakarinen E, Lehtonen L, Abo-Ramadan U, Lindholm P, Zheng C, Harvey B, Arumäe U, Lindahl M, Airavaara M.

Sci Adv. 2018 May 23;4(5):eaap8957. doi: 10.1126/sciadv.aap8957. eCollection 2018 May.

4.

Post-stroke Intranasal (+)-Naloxone Delivery Reduces Microglial Activation and Improves Behavioral Recovery from Ischemic Injury.

Anttila JE, Albert K, Wires ES, Mätlik K, Loram LC, Watkins LR, Rice KC, Wang Y, Harvey BK, Airavaara M.

eNeuro. 2018 Apr 18;5(2). pii: ENEURO.0395-17.2018. doi: 10.1523/ENEURO.0395-17.2018. eCollection 2018 Mar-Apr.

5.

Synthesis of 7β-hydroxy-8-ketone opioid derivatives with antagonist activity at mu- and delta-opioid receptors.

Ahonen TJ, Rinne M, Grutschreiber P, Mätlik K, Airavaara M, Schaarschmidt D, Lang H, Reiss D, Xhaard H, Gaveriaux-Ruff C, Yli-Kauhaluoma J, Moreira VM.

Eur J Med Chem. 2018 May 10;151:495-507. doi: 10.1016/j.ejmech.2018.02.074. Epub 2018 Mar 26.

PMID:
29649744
6.

Differential Spinal and Supraspinal Activation of Glia in a Rat Model of Morphine Tolerance.

Jokinen V, Sidorova Y, Viisanen H, Suleymanova I, Tiilikainen H, Li Z, Lilius TO, Mätlik K, Anttila JE, Airavaara M, Tian L, Rauhala PV, Kalso EA.

Neuroscience. 2018 Apr 1;375:10-24. doi: 10.1016/j.neuroscience.2018.01.048. Epub 2018 Feb 6.

PMID:
29421434
7.

Intrastriatally Infused Exogenous CDNF Is Endocytosed and Retrogradely Transported to Substantia Nigra.

Mätlik K, Vihinen H, Bienemann A, Palgi J, Voutilainen MH, Booms S, Lindahl M, Jokitalo E, Saarma M, Huttunen HJ, Airavaara M, Arumäe U.

eNeuro. 2017 Feb 20;4(1). pii: ENEURO.0128-16.2017. doi: 10.1523/ENEURO.0128-16.2017. eCollection 2017 Jan-Feb.

8.

Developing therapeutically more efficient Neurturin variants for treatment of Parkinson's disease.

Runeberg-Roos P, Piccinini E, Penttinen AM, Mätlik K, Heikkinen H, Kuure S, Bespalov MM, Peränen J, Garea-Rodríguez E, Fuchs E, Airavaara M, Kalkkinen N, Penn R, Saarma M.

Neurobiol Dis. 2016 Dec;96:335-345. doi: 10.1016/j.nbd.2016.07.008. Epub 2016 Jul 15.

PMID:
27425888
9.

Role of two sequence motifs of mesencephalic astrocyte-derived neurotrophic factor in its survival-promoting activity.

Mätlik K, Yu LY, Eesmaa A, Hellman M, Lindholm P, Peränen J, Galli E, Anttila J, Saarma M, Permi P, Airavaara M, Arumäe U.

Cell Death Dis. 2015 Dec 31;6:e2032. doi: 10.1038/cddis.2015.371.

10.

From microRNA target validation to therapy: lessons learned from studies on BDNF.

Varendi K, Mätlik K, Andressoo JO.

Cell Mol Life Sci. 2015 May;72(9):1779-94. doi: 10.1007/s00018-015-1836-z. Epub 2015 Jan 20. Review.

11.

AAV-mediated targeting of gene expression to the peri-infarct region in rat cortical stroke model.

Mätlik K, Abo-Ramadan U, Harvey BK, Arumäe U, Airavaara M.

J Neurosci Methods. 2014 Oct 30;236:107-13. doi: 10.1016/j.jneumeth.2014.08.014. Epub 2014 Aug 23.

12.

Glia cell line-derived neurotrophic factor mediates survival of murine sympathetic precursors.

Heermann S, Mätlik K, Hinz U, Fey J, Arumae U, Krieglstein K.

J Neurosci Res. 2013 Jun;91(6):780-5. doi: 10.1002/jnr.23188. Epub 2013 Feb 21.

PMID:
23426908
13.

PCSK9 regulates neuronal apoptosis by adjusting ApoER2 levels and signaling.

Kysenius K, Muggalla P, Mätlik K, Arumäe U, Huttunen HJ.

Cell Mol Life Sci. 2012 Jun;69(11):1903-16. doi: 10.1007/s00018-012-0977-6. Epub 2012 Apr 6.

PMID:
22481440
14.

Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus.

Autio H, Mätlik K, Rantamäki T, Lindemann L, Hoener MC, Chao M, Arumäe U, Castrén E.

Neuropharmacology. 2011 Dec;61(8):1291-6. doi: 10.1016/j.neuropharm.2011.07.033. Epub 2011 Jul 30.

15.

Persephin signaling through GFRalpha1: the potential for the treatment of Parkinson's disease.

Sidorova YA, Mätlik K, Paveliev M, Lindahl M, Piranen E, Milbrandt J, Arumäe U, Saarma M, Bespalov MM.

Mol Cell Neurosci. 2010 Jul;44(3):223-32. doi: 10.1016/j.mcn.2010.03.009. Epub 2010 Mar 27.

PMID:
20350599
16.

Combination of native and denaturing PAGE for the detection of protein binding regions in long fragments of genomic DNA.

Kaer K, Mätlik K, Metsis M, Speek M.

BMC Genomics. 2008 Jun 4;9:272. doi: 10.1186/1471-2164-9-272.

17.

L1 antisense promoter drives tissue-specific transcription of human genes.

Mätlik K, Redik K, Speek M.

J Biomed Biotechnol. 2006;2006(1):71753.

18.

Many human genes are transcribed from the antisense promoter of L1 retrotransposon.

Nigumann P, Redik K, Mätlik K, Speek M.

Genomics. 2002 May;79(5):628-34.

PMID:
11991712

Supplemental Content

Loading ...
Support Center